Human Vaccines & Immunotherapeutics
ISSN:2164-5515

Human Vaccines & Immunotherapeutics

HUM VACC IMMUNOTHER
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:一般,3-6周
新锐分区:医学3区
年发文量:467
影响因子:3.5
JCR分区:Q2

基本信息

(以前称为人类疫苗; ISSN 1554-8619)疫苗研究和开发正在将其范围扩展到预防细菌或病毒疾病之外。存在用于免疫治疗目的的实验性疫苗和用于感染性疾病以外的应用,在诸如癌症、自身免疫、变态反应、阿尔茨海默氏病和成瘾的不同领域中。这些疫苗和免疫疗法中的许多将在未来20年内问世,从而有利于人类健康。该领域的持续发展将受益于一个论坛,该论坛可以(A)通过让研究者了解最新情况来帮助提高兴趣,(B)使人们能够就疫苗和免疫治疗学的许多主题的最新进展交换意见。人类疫苗和免疫治疗学提供了这样一个论坛。它每月出版一次,以学术界、工业界和公共部门的广大国际读者都可以查阅的格式出版。
2164-5515SCIE/Scopus收录/DOAJ开放期刊
3.5
3.9
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
2区
IMMUNOLOGY 免疫学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
Q2
65/177
学科:IMMUNOLOGY
SCIE
Q2
81/183
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
Q2
68/177
学科:IMMUNOLOGY
SCIE
Q2
77/183
43
467
13%容易一般,3-6周-BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY
8.6%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
84.37%99.43%-
CiteScore:7.90
SJR:0.897
SNIP:0.890
学科类别分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q1
62 / 321
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Immunology and Allergy
Q2
60 / 231
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Immunology
Q2
71 / 240

期刊高被引文献

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1651141
A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1593082
The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1565269
Perspectives and preferences for a mobile health tool designed to facilitate HPV vaccination among young men who have sex with men
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1568156
Knowledge, attitudes and factors associated with acceptability of human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1565260
Economic evaluation of adolescents and adults’ pertussis vaccination: A systematic review of current strategies
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1509646
In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1627820
Influenza vaccination in health-care workers: an evaluation of an on-site vaccination strategy to increase vaccination uptake in HCWs of a South Italy Hospital
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1625645
Application of quality improvement approaches in health-care settings to reduce missed opportunities for childhood vaccination: a scoping review
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1600988
Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1682845
Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1593727
Improving influenza vaccination uptake among healthcare workers by on-site influenza vaccination campaign in a tertiary children hospital
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1575164
Immunological considerations in the development of Pseudomonas aeruginosa vaccines
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1650999
Challenges facing vaccinators in the 21st century: results from a focus group qualitative study
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1621147
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1540828
Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1688035
Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1678998
Evaluation of two frailty indices, with practical application in a vaccine clinical trial
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1622974
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1549449
Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1591138
Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1551701
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1627818
Letter to the editor: female sex workers and HPV vaccine
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1633880
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1619402
Empathy in vaccination counselling: a survey on the impact of a three-day residential course
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1536587
A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1649551
Influenza vaccination in pregnancy: careful assessment confirms safety concerns for the offspring
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1605818
Association of cognitive biases with human papillomavirus vaccine hesitancy: a cross-sectional study
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1698243
Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1565259
Primary physicians’ attitudes toward their patients receiving a proposal to participate in a vaccine trial
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1625646
Finding a way to address a wicked problem: vaccines, vaccination, and a shared understanding
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1695458
The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1680084
Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles–rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1616502
Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014–2015 and 2015–2016 influenza seasons: a cohort study
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1528832
Hepatitis B vaccine birth dose in India: time to reconsider
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1640557
Reliability and validity of a survey to identify vaccine hesitancy among parents in Changxing county, Zhejiang province
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1572409
Failure of postexposure prophylaxis in a girl child attacked by rabid dog severing her facial nerve causing possible direct entry of rabies virus into the facial nerve
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1608131
Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1691404
Human Vaccines & Immunotherapeutics: news
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1642665
Letter from the Editor
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1661161
A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1509648
From the wild west to the frontiers of immunology: the journey of a Chinese-American scientist
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1597583
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1581541
Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1589282
5TH ESCMID Conference on Vaccines in Bilbao, Spain. Vaccines against respiratory infections: new insights and new vaccines
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1678999
Letter from the Editor
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1680022
Comment on Gomez et. al. “Response to article by Wasserman et. al. (2018) ‘Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico’”
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2018.1558691
Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1575573
Human Vaccines & Immunotherapeutics: news
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1691423
Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years
来源期刊:Human Vaccines & ImmunotherapeuticsDOI:10.1080/21645515.2019.1670125

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学3区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
2区
IMMUNOLOGY 免疫学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
3区
IMMUNOLOGY 免疫学
3区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物
3区
IMMUNOLOGY 免疫学
4区